For research use only
| Cat No. | ABC-TC0033 |
| Product Type | Human Head And Neck Cancer Cell lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Product Code | A64 CBR, A64CBR, a64-cbr |
Established from the primary adenoma from the submaxillary gland.
A64-CBR is a human epithelial tumor cell line established from a primary adenoma of the submaxillary gland, one of the major salivary glands, in an adult patient diagnosed with benign epithelial neoplasm of the head and neck region. The cells display polygonal epithelial morphology and grow as an adherent monolayer under standard culture conditions. A64-CBR retains morphological and phenotypic characteristics of glandular origin and expresses cytokeratins associated with ductal epithelial cells, supporting its classification as a salivary gland–derived tumor model. Despite its benign origin, the line exhibits continuous proliferation in vitro, making it suitable for transformation studies. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | A64 CBR, A64CBR, a64-cbr |
| Species | Human |
| Cat.No | ABC-TC0033 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Head And Neck Cancer Cell lines |
A64-CBR provides an ideal model system for studying the molecular and cellular characteristics of human salivary gland adenomas and the broader class of head and neck glandular tumors. Its epithelial morphology and retained gland-specific features enable investigation into epithelial differentiation, secretory functions, and early oncogenic transformation events. The line is especially valuable for research exploring the transition from benign to malignant phenotypes, biomarker discovery, and testing potential diagnostic markers. A64-CBR can also support drug screening protocols targeting salivary gland tumor pathways or epithelial tissue response. Its reproducible growth properties make it well suited for translational and preclinical cancer research models.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
